Tag: Drug Approvals
FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
FDA Approves Lonsurf for Metastatic Colorectal Cancer
For patients with metastatic CRC previously treated with chemotherapy, biological therapy
FDA Approves New Drug for Schizophrenia, Bipolar Disorder
Vraylar is an atypical antipsychotic taken once a day
FDA Approves Varubi for Chemo-Induced Nausea, Vomiting
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
FDA Approves Repatha for Certain Patients With High Cholesterol
Approved for patients unable to get LDL cholesterol under control with current treatment options
Promacta Approval Expanded for Children With Chronic ITP
Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura
FDA Approves Libido Pill for Women
Addyi to treat generalized hypoactive sexual desire disorder among premenopausal women
FDA Approves Balloon Device to Treat Obesity
Inflated in stomach, it may create sense of fullness
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
